KRTL BioTech

Jon Medved Steps Down as OurCrowd CEO After ALS Diagnosis

Jon Medved Steps Down as OurCrowd CEO After ALS Diagnosis

OurCrowd | Oct 22, 2025 CEO Jon Medved Transitions to Chairman of OurCrowd Following ALS Diagnosis On October 21 2025, as reported by several news outlets, OurCrowd announced on Tuesday that Founding CEO Jon Medved will move into the role of Chairman after being diagnosed with ALS, also known as Lou Gherig’s disease. OurCrowd named


The post Jon Medved Steps Down as OurCrowd CEO After ALS Diagnosis first appeared on National Crowdfunding & Fintech Association of Canada.